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Some of the most serious diseases involve altered
size and structure of the arterial wall. Elucidating
how arterial walls are built could aid understanding
of these diseases, but little is known about how
concentric layers of muscle cells and the outer ad-
ventitial layer are assembled and patterned around
endothelial tubes. Using histochemical, clonal, and
genetic analysis in mice, here we show that the
pulmonary artery wall is constructed radially, from
the inside out, by two separate but coordinated
processes. One is sequential induction of successive
cell layers from surrounding mesenchyme. The other
is controlled invasion of outer layers by inner layer
cells through developmentally regulated cell re-
orientation and radial migration. We propose that
a radial signal gradient controls these processes
and provide evidence that PDGF-B and at least one
other signal contribute. Modulation of such radial
signaling pathways may underlie vessel-specific
differences and pathological changes in arterial wall
size and structure.
INTRODUCTION
Although there has been remarkable progress over the past
decade elucidating the cellular and molecular mechanisms of
the critical early events in blood vessel development, generation
of new endothelial tubes by vasculogenesis and angiogenesis
(Adams and Alitalo, 2007; Carmeliet, 2005; Jin et al., 2005;
Phng and Gerhardt, 2009; Strilic et al., 2009; Weinstein and Law-
son, 2002), relatively little is known about the subsequent events
that create and pattern the arterial wall (Greif, 2012; Hungerford
and Little, 1999; Hungerford et al., 1996; Schwartz, 1997). A
mature arterial wall typically consists of an endothelial monolayer
surrounded by multiple concentric rings of smooth muscle
cells (SMCs), up to a few dozen or more layers, which dominate
the mature arterial wall and provide it with structural integrity
and contractility, plus an outer adventitial layer consisting of482 Developmental Cell 23, 482–493, September 11, 2012 ª2012 Elsfibroblasts embedded in a collagen matrix. In many arteries
there are also structural specializations such as an elastic layer
separating the endothelial cells (ECs) from the vascular smooth
muscle cells (VSMCs), and elastic fibers embedded in the
smooth muscle layer and other cellular and molecular features
that structurally subdivide and pattern the smooth muscle com-
partment (tunica media) (Frid et al., 1994, 1997; McLean et al.,
2005; Wolinsky and Glagov, 1967). The size and pattern of the
smooth muscle layer are carefully controlled in a vessel-specific
manner during development, but are dysregulated in many
prominent cardiovascular diseases such as aortic aneurysm,
coronary artery atherosclerosis and pulmonary hypertension.
Current models of arterial wall development posit that nascent
endothelial tubes recruit SMC progenitors, which can apparently
arise from a variety of sources (DeRuiter et al., 1997; Esner et al.,
2006; High et al., 2007; Jiang et al., 2000; Le Lie`vre and Le
Douarin, 1975; Majesky, 2007; Morimoto et al., 2010; Que
et al., 2008; Wasteson et al., 2008; Wilm et al., 2005; Yamashita
et al., 2000) and induce them to differentiate into VSMCs. Several
signaling pathways have been implicated in VSMC migration or
differentiation (Domenga et al., 2004; Gaengel et al., 2009;
Hirschi et al., 1998; Lindahl et al., 1997; Mizugishi et al., 2005;
Owens et al., 2004; Suri et al., 1996), but how these cells are
recruited and organized into a radially patterned structure with
the appropriate number and identity of layers is not well under-
stood. Here we describe the development of the pulmonary
artery (PA) wall using histochemical, clonal, and genetic analysis
in mice. We show that the wall is constructed radially, from the
inside out, by sequential induction and recruitment of successive
cell layers from surroundingmesenchymal cells, and by develop-
mentally regulated invasion of outer layers by inner layer cells.
We also show that the endothelial-specific ligand PDGF-B can
initiate wall formation but provide genetic evidence that one or
more other, as yet unidentified, signals also contribute to the
initiation and radial patterning of the wall.RESULTS AND DISCUSSION
Pulmonary Artery Smooth Muscle Cells Arise from Lung
Mesenchyme
To elucidate the cellular and molecular events of arterial wall
formation, we focused on a small region of a developing mouseevier Inc.
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Figure 1. Pulmonary Artery Smooth Muscle Cells Derive from Lung Mesenchyme
(A) Ventral view of whole mount lung at embryonic day (E) 12.5 immunostained for E-cadherin (airway epithelium, green) and PECAM (endothelium, red). Box,
portion of left pulmonary artery (PA) investigated here, from carina (ca) to LL1 (first lateral secondary branch off left primary bronchus) (Metzger et al., 2008). LL2
and LL3, second and third lateral secondary branches. (B and C) Longitudinal sections of left PA at E18.5 stained with hematoxylin and eosin (H&E) (B) or
immunostained for a-smoothmuscle actin (SMA, red), PDGFR-b (green) and counterstained with DAPI (nuclei, blue) (C). E, endothelial cell (EC) layer; 1, first (inner)
smooth muscle cell (SMC) layer; 2, second SMC layer; A, adventitial cell layer. Lu, PA lumen. (D) Schematic of B and C, showing ECs (black), SMCs (red) and
adventitial cells (green).
(E and F) Lineage tracing using theWt1-CreERT2 and the Tbx4-CreERT2 transgenes as indicated with the mTmGCre reporter to determine the contribution of the
mesothelium and lung mesenchyme, respectively, to the PA wall. Longitudinal sections are shown of one side of the E18.5 left PA wall stained for the Cre reporter
(green) and PECAM (white), SMA (red), and DAPI (blue) to visualize the PA wall. Pregnant dams were injected with a single dose of tamoxifen (3 mg at E9.5 in E;
1.5 mg at E10.5 in F) to activate the Cre(ER) recombinase. Inset in (E) shows in the same specimen lineage-labeled cells in the lung mesothelium, outside the PA.
Lineage trace of lung mesenchyme (F; also see Figure S1C), but not mesothelium (E), labels PA wall cells, and the fraction of lineage labeled PA wall cells with the
Tbx4-CreERT2 in F is similar to the overall lungmesenchyme labeling efficiency (data not shown). (G–I) PDGFR-b expression around developing PA.Whole mount
lungs at indicated ages immunostained for PDGFR-b (G and I) and PECAM (endothelium, H). I’, Confocal optical section of boxed region of left PA in I showing
both PDGFR-b and PECAM staining. I’’, Schematic of I’ showing zone of PDGFR-b (green) cells surrounding developing left PA ECs (black) (I’’). J, Lineage trace
(as in E and F) of PDGFR-b expressing cells. All cells of E18.5 PA wall are marked by lineage tag (green).
Scale bars, 100 mm (A, G–I) and 10 mm (B, C, E, F, I’, J). See also Figures S1, S2A, S2C, and S2D.
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Radial Construction of an Arterial Wallartery, the left PA between the level of the carina (ca) and first
branch off the left bronchus (LL1; Figure 1A). We selected this
artery because of its relatively simple structure at birth, justDevelopmentwo and occasionally three SMC layers plus an outer adventitial
layer (Figures 1B–1D), the ease and precision in its identification
and developmental staging provided by the adjacent bronchialtal Cell 23, 482–493, September 11, 2012 ª2012 Elsevier Inc. 483
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Figure 2. Radial Development of the PA Wall
Longitudinal sections through the left PA wall at the embryonic ages indicated,
stained for SMA (red), PDGFR-b (green), and nuclei (DAPI, blue) as indicated.
Arrowheads, nuclei elongated longitudinally. The inset in (E) shows a trans-
verse section through the left PA wall. Schematics at bottom summarize
SMA (red) and PDGFR-b (green) expression (orange, co-expression of
SMA and PDGFR-b) and cell shape and orientation changes in the forming
layers (E, 1, 2, A) of the developing PA wall. Lu, PA lumen. Square cells,
circumferentially oriented cells. Scale bars, 10 mm. See also Figure S2.
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2008), and its involvement in devastating diseases such as
pulmonary hypertension.
We carried out lineage tracing with cell- and tissue-specific
Cre transgenes to investigate the developmental origin of PA
SMCs. Previous studies have shown that SMCs of the outflow
tract of the right heart originate at least in part from neural crest
(Kirby et al., 1983; Majesky, 2007), but SMCs of more distal
segments of the PA have been proposed to arise largely from
lung mesothelial cells (Que et al., 2008) and ECs (Morimoto
et al., 2010) by epithelial- and endothelial-to-mesenchymal
transitions. However, our analysis of PA SMCs in E18.5 lungs
following lineage tracing with Wilm’s tumor 1 (Wt1)-CreERT2
(mesothelium), VE-cadherin-Cre (endothelium), Wnt1-Cre
(neural crest), and Sonic hedgehog-Cre (epithelium) transgenes484 Developmental Cell 23, 482–493, September 11, 2012 ª2012 Elsin conjunction with the ROSA26RmTmG Cre reporter showed
that mesothelium, endothelium, neural crest, and airway epithe-
lium are not substantial sources of SMCs of the PA during this
period (Figure 1E; Figures S1A and S1B available online; data
not shown). In contrast, lineage tracing with a recently generated
lung mesenchyme-specific conditional transgene Tbx4-CreERT2
(M.K., P. Bogard, and M.A.K., unpublished data; Menke et al.,
2008), induced at E10.5, resulted in substantial labeling of
E18.5 PA cells expressing the SMC marker alpha-smooth
muscle actin (SMA), demonstrating that Tbx4+ lung mesen-
chyme is a major, and possibly the sole source of PA SMCs at
this stage (Figures 1F and S1C).
Induction of the First Layer of Arterial Smooth Muscle
At E11, the first layer of the PA wall begins to form by a stereo-
typed sequence ofmolecular and cellular events that occur in the
mesenchymal cells surrounding the nascent PA endothelial tube
(Figure 2). Platelet-derived growth factor receptor (PDGFR)-b is
initially expressed diffusely in the proximal lung mesenchyme
(Figure 1G), when pulmonary ECs form a widely distributed
plexus (Parera et al., 2005; P. Bogard, M.K., R. Metzger, and
M.A.K., unpublished data; Figure 1H). But during the next day
its expression begins to restrict to the group of mesenchymal
cells surrounding the nascent PA endothelial tube, in the domain
that will form the arterial wall (Figures 1I, 1I’, 1I’’) (see below).
Beginning at E11.5, smooth muscle markers such as SMA
are induced in the PDGFR-b+ cells directly contacting the PA
EC tube (Figures 2A and 2B). SMA is initially expressed at low
levels and in a discontinuous fashion along the length of the
PA, with more expressing cells on the lateral than the medial
aspect of the vessel and localization of SMA protein initially
polarized toward the side of the cell contacting the EC layer
(Figures S2A, S2B, and S2B’). Other SMC markers also initiate
expression at this time including smooth muscle myosin heavy
chain (SMMHC) (Miano et al., 1994), the actin and tropomyosin
binding protein SM22-alpha, and the transmembrane protein
neuron glial-2 (NG2) (Figure S2F; data not shown). The expres-
sion of all four of these SMC markers increases over the next
few days, forming a robustly labeled layer of smooth muscle
(Figures 2C–2F and S2C; data not shown).
As SMC markers are induced in first layer cells, PDGFR-b
expression is downregulated in these cells (Figure S2C) and
by E18.5, expression was generally not detected in them (Fig-
ure S2D). Permanent marking of early PDGFR-b-expressing
cells with a PDGFR-b-Cre transgene (Foo et al., 2006) (Fig-
ure S1E) labeled almost all SMA+ PA wall cells at E18.5 (Figures
1J and S1D), including inner layer cells that do not express
PDGFR-b at this time, confirming their origin from cells that
initially expressed the gene.
During this period of dynamic marker expression, first layer
cells reorient. Initially, at E11.5, many first layer SMA+ cells and
their nuclei were elongated longitudinally along the blood vessel
(Figures 2A and 2B, ‘‘alignment’’). However, over the next few
days, first layer cells shortened along their longitudinal axis
(Figures 2C and 2D, ‘‘shortening’’), and by E14.5 they were cir-
cumferentially oriented (Figures2E, 2F, andS2E, ‘‘reorientation’’),
as they are in the mature vessel. Thus, over a 3 day period (E11.5
to E14.5), the first layer of the PA wall forms by a stereotyped
series of cell marker and morphogenesis events.evier Inc.
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of the Arterial Wall
A few days after first layer cells initiate the arterial wall program,
surrounding mesenchymal cells initiate a similar series of
events to form the second layer of the arterial wall. At E13.5,
these second layer cells express PDGFR-b and are elongated
longitudinally, as first layer cells were 2 days earlier (Figures
2C and 2D). The next day smooth muscle markers begin to
be expressed in these cells (Figures 2E and 2F), and as smooth
muscle marker expression increases over the next several
days, these cells downregulate PDGFR-b expression (Fig-
ure S2D), similar to the changes noted in first layer cells several
days earlier. During this time, most of the cells shorten in the
longitudinal axis and reorient to a circumferential orientation,
forming the second layer of the arterial wall (Figures 1B, 1C,
2G, and 2H).
As the second layer is forming, cells surrounding this layer
initiate a similar program to form the outer layer of the arterial
wall. At E14, these outer layer cells express PDGFR-b and
are elongated longitudinally along the artery (Figures 2C and
2D), like early first and second layer cells. However, the outer
layer cells do not progress through the full program. By E18.5,
they have not turned on SMC markers or downregulated
PDGFR-b expression, and they have not undergone longitudinal
shortening or reorientation (Figures 1B, 1C, 2G, and 2H). Thus,
outer layer cells initiate the arterial wall program but arrest
early on, forming the adventitial layer of the wall. These cells
do not appear to complete the program, at least not during
embryogenesis.
Taken together, the results show that the PA wall is con-
structed radially, from the inside-out, by sequential activation
of an arterial wall program in three successive cell layers.
Radial Patterning of Cell Division in the Arterial Wall
We next investigated cell division in the developing arterial wall
by immunostaining for the mitotic marker phosphohistone H3
(pH3). There were two unexpected results. First, although undif-
ferentiated progenitor cells are thought, in general, to become
less proliferative as they differentiate into VSMCs (Owens
et al., 2004), we found just the opposite in the developing PA
wall. The vast majority of pH3+ mitotic cells (Figure 3A) of the
E11.5–14.5 PAwall are found in the inner (Figure 3B), more differ-
entiated layers (Figure 3C), most in the innermost layer directly
contacting the endothelial tube (layer 1). Cells that turn on
SMA maintain their proliferative index, whereas the proliferative
index of cells that do not declines (Figure 3D).
Second, we found that proliferating inner layer cells undergo
a developmental shift in division plane orientation. In the early
stages of PA wall development (E11.5–13.5), the axis of division
of cells in the inner layer (L1) was predominately (>75%)
longitudinal (Figures 3E and 3F). However, at E14.5 the axis
shifts so that most (75%) inner layer cells now divide radially
(Figures 3E and 3F). This shift is specific to the innermost
layer: cells in layer two (L2) and the adventitia (A) divide exclu-
sively longitudinally at this stage (Figure 3F). Below we show
by clonal analysis that this shift in division plane orientation
corresponds with a transition of inner layer cells to a radially
invasive mode in which they enter and help populate the
surrounding cell layer.DevelopmenClonal Analysis of Inner Layer Cells Reveals a Transition
to a Radially Invasive Growth Mode
A clonal analysis was carried out in which individual first layer
SMCs were genetically marked to track their proliferative
potential and the final positions and pattern of the daughter cells
(Figure 4A). To label first layer cells with GFP, Cre-mediated
recombination was induced in transgenic SMMHC-creERT2,
ROSA26RmTmG/+ embryos using a single limiting dose (0.8–
1.2 mg) of tamoxifen at E11.5, a stage at which SMMHC is ex-
pressed exclusively in the first layer of the developing PA wall.
This resulted in rare or no GFP+ cells within the entire visualized
region of the left PA, so that labeled cells likely derived from
a single recombination event. The putative PA wall clones were
scored only if among SMMHC-creERT2, ROSA26RmTmG/+ litter-
mates, there was at least one embryo without marked cells in
this region. Similar experiments using a multi-color Rainbow
Cre reporter ROSA26RRb/+ (Red-Horse et al., 2010) showed
that all labeled cells in individual left PAs were almost always
of a single color, confirming their clonal relationship (see Exper-
imental Procedures). From an analysis of the size of clones
between E13.5 and E18.5, we estimate the proliferation rate
(doubling time) of PA SMCs as 1.0 ± 0.4 days from E12 to E14,
slowing to 3.8 ± 1.9 days from E14 to E18 (Table S1). (In
comparison to these experiments with limiting doses of tamox-
ifen, a single high dose of tamoxifen labeled substantially more
inner layer cells and formed multicolored ‘‘polyclones,’’ as ex-
pected; Figures S3A–S3C.)
The positions of daughter cells in 32 PA wall clones derived
from individual inner layer cells marked with a limiting dose of
tamoxifen at E11.5 and observed at E13.5–18.5 are given in Fig-
ure S4 and Table S1. Daughter cells could potentially distribute
in longitudinal, circumferential, and radial directions, and the
cells could remain contiguous and form a coherent clone or inter-
mingle with unmarked cells to form adispersed clone (Figure 4A).
At E13.5, marked cells have proliferated and many daughters
have migrated extensively along the longitudinal and circumfer-
ential axes, often separating from sibling cells and intermixing
with unlabeled cells (Figures 4B, 4C, 4E, and S4). All the daughter
cells, however, remain within the inner, SMA+ cell layer. A day
later, at E14.5, this restriction to radial migration is relaxed, and
daughter cells begin to invade the second layer (Figures 4E,
S3D, S3E, and S4). Only a small percentage (12.5%) of marked
first layer cells (n = 56) have invaded the second layer at E14.5,
increasing to 32% by E17.5–18.5 with marked daughter cells
found throughout the first and second layers (Figures 4D, 4E,
and S4; data not shown). The relaxation of the radial restriction
is only partial: although marked inner layer cells migrated exten-
sively in the first and second layers, they did not invade the
developing adventitial or intimal layers at this stage (Figure S4).
Because there is a full (albeit immature) second layer at E14.5
(Figures 2E and 2F), we infer that most second layer cells arise
from induction of surrounding (i.e., second layer or beyond)
lung mesenchyme (see lineage analysis, Figures 1F, 1J, and
S1C), rather than radial movement of inner layer cells.
A classical clonal analysis of the abdominal aortic wall in adult
women using X chromosome-inactivation (analyzed by PCR) as
a crude clone marker suggested limited dispersal of sibling cells
in most clones (Chung et al., 1998; Schwartz andMurry, 1998), in
contrast to the extensive cell migration and mixing we observe.tal Cell 23, 482–493, September 11, 2012 ª2012 Elsevier Inc. 485
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Figure 3. Radial Patterning of Cell Division in the Developing PA Wall
(A) Representative confocal optical section of left PA at E14.5 stained for themitosismarker phosphohistone H3 (pH3, white) and SMA (red), PDGFR-b (green) and
nuclei (DAPI, blue) to assign cell layer (1, 2, A) of each dividing cell. The inset shows a close up of a dividing cell and its assigned cell layer.
(B) Distribution of dividing cells among the three cell layers. Values shown are the fraction of all dividing (pH3+) left PA wall cells located in each cell layer, for each
embryonic age indicated. The total number of PA walls analyzed and dividing cells scored were: E11.5 (16 walls, 32 dividing cells), E12.5 (12, 31), E13.5 (14, 37)
and E14.5 (15, 70).
(C) Marker expression pattern of dividing PA wall cells. Values shown are the fraction of all proliferating (pH3+) left PA wall cells that were SMA+ or PDGFR-b+/
SMA. The number of PA walls analyzed and dividing cells scored were: E13.5 (18, 48) and E14.5 (16, 80).
(D) Proliferative index of PA wall cells. Values shown are the proliferative index (fraction pH3+ cells) of SMA+ cells and PDGFR-b+/SMA cells of the PA wall at
the ages indicated. The number of left PA walls analyzed and cells scored were: E13.5 (18 walls, 1286 SMA+ cells, 1111 PDGFR-b+/SMA cells) and E14.5
(16, 3024, 519). Errors bars, s.e.m. *p = 0.019 by Student’s t test.
(E) Schematic (top) and representative confocal images of stained lungs (bottom) showing longitudinal and radial axes of cell division in developing PAwall. Lungs
were stained for pH3, SMA, and DAPI as indicated. Dashed circles, daughter chromosomes of dividing cell.
(F) Fraction of longitudinal versus radial cell divisions in the indicated layers of the PA wall at the indicated ages. After E13.5, layer 1 (L1) cells switch from
predominantly longitudinal to predominantly radial division. The ‘‘0’’ in the panel indicates no detected radial cell divisions in the L2 and A layers at E14.5. The
number of mitotic figures scored at E11.5–13.5 was 22 in L1 and at E14.5 was 15 in L1 and 12 in L2 and A. **p = 0.003, ***p = 0.0002 by Fisher’s exact test.
Scale bars, 10 mm.
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clone markers to determine if this difference represents a funda-
mental difference between the vessels, organisms, or stages of
development, or a limitation of the earlier clone marking and
analysis strategy.
AGradient Model for Radial Patterning of the Pulmonary
Artery Wall
Our results show that the PA wall is constructed radially, from
the inside out (Figure 5A), by two separate but coordinated
processes. One is sequential induction and recruitment of
successive cell layers from surrounding mesenchymal progen-
itor cells. Each layer of mesenchymal cells initiates a program
of gene expression and undergoes a stereotyped sequence of
morphogenesis events over a 3 day period; as one muscle layer
forms, the next layer initiates development. The program arrests486 Developmental Cell 23, 482–493, September 11, 2012 ª2012 Elsearly in the formation of the outermost layer to generate the
adventitial layer. The other process is controlled invasion of the
surrounding layer by inner layer cells, which initially divide and
migrate extensively within the layer but later radially reorient
and either migrate into the second layer or radially divide and
send daughter cells into the next developing layer. Because
this transition to radial invasion coincides with the switch from
circumferential to primarily radial cell division, it could be that
inner cells only enter an outer layer by radial cell division. Such
coupling of centrifugal movement to cell division would prevent
depletion of first layer cells, while supplying extra cells needed
in the outer layers given their greater circumference but paradox-
ical dearth of proliferating cells.
We propose that a radial signaling gradient controls and
coordinates the two processes (Figure 5B). The likely source of




Figure 4. Clonal Analysis of Inner Layer Cells of the PA Wall
(A) Clonal analysis scheme showing early (E11.5) marking of an inner layer cell and four possible patterns of its proliferation and migration: longitudinal (L),
circumferential (C), and radial (R) expansion, and longitudinal with mixing with unlabeled cells (L,M).
(B) A GFP-marked left PA clone (#9, Table S1) in a SMMHC-CreERT2, ROSA26RmTmG/+ embryo, induced by administration of a limiting dose of tamoxifen at E11.5
and analyzed at E13.5 after staining for clone marker (membrane-localized GFP, abbreviated ‘‘mG,’’ green) and for SMA (red), PECAM (white) and nuclei (DAPI,
blue). An individual coronal confocal optical section (dorsal view, anterior up) of the four-cell clone is shown (left panel) along with a maximal projection (center
panel). 1–4, cells of clone; Lu, PA lumen. In the clone schematic (right panel), the positions of marked cells are indicated by circles color coded to highlight the
layer in which the cell resides: green (layer 1), red (layer 2), and blue (adventitia). For cells located superficial (gray circles) or deep (white circles) to the lumen, we
were unable to determine which layer they reside in (nd, not determined). This clone expanded longitudinally (L) and circumferentially (C), with mixing (M). ca,
position of carina; LL1, position of LL1 airway branch.
(C) Six cell clone (#11), induced and analyzed as in B. Two confocal optical sections are shown, along with a maximal projection and schematic. Dashed box,
portion of clone shown in the confocal images.
(D) Sixteen cell clone (#30), induced and analyzed as in B, except clone marker was multicolor (Rainbow, abbreviated ‘‘Rb’’) ROSA26RRb Cre reporter and the
clone was analyzed at E18.5. Left panel, Cerulean channel of confocal image (ventral view) of coronal cryosection of the clone: bright cells are Cerulean-
expressing cells of clone (numbered). Faint background staining shows the rest of the SMCs of PA wall. Center panel, Cerulean, mOrange andmCherry channels
of the same cryosection. All labeled cells in left PA express Cerulean marker, confirming clonality. Clone expanded in all three axes (L, C, and R), with some cells
(red in schematic) having invaded layer 2. For clarity, only every other cell in the schematic is numbered.
(E) Schematics (ventral views) of other representative clones. Although layer 1 clones can expand and mix extensively within layer 1, they do not expand radially
into layer 2 until E14.5. By E18.5, they have spread extensively in layers 1 and 2, but have not invaded the adventitial layer. mG, mGFP clonemarker; Rb, Rainbow
(multicolor) clone marker. Scale bars, 10 mm.
See also Table S1 and Figures S3 and S4.
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Figure 5. Signal Gradient Model for PA Wall Patterning and Involvement of PDGF Pathway
(A) Summary of cellular and molecular events in radial construction of PA wall. Cell wall progenitor zone surrounding PA endothelial tube is initially marked by
PDGFR-b expression (green cells). Innermost cells (adjacent to endothelium, E) initiate smooth muscle marker expression and morphogenesis (orange cells) and
then downregulate PDGFR-b (red cells) to form layer 1. Smoothmuscle cycle repeats to form layer 2, and third cycle initiates to form adventitial (A) layer. As layer 1
cells mature, they radially reorient cell division and migration, sending daughter cells outward to supplement layer 2. R (radial), L (longitudinal), C (circumferential)
cell division and migration.
(B) Gradient of a hypothetical radial signal that sequentially induces cell layers surrounding the endothelium to differentiate into the vascular wall. Different identity
thresholds (1, 2, 3) result in differences among layers (e.g., smooth muscle versus adventitia, or high versus low elastin expression). The signaling gradient could
also control the radial reorientation of cell division and migration.
(C) Whole mount lung in situ hybridization of the ligand PDGF-B, a candidate for the radial signal. Gene is expressed in ECs of developing PA (arrowheads).
(D and E) Confocal images of whole mount lungs from wild-type littermates implanted with a control or PDGF-B-soaked bead as indicated, cultured for 72 hr and
then stained for PDGFR-b (green), SMA (red), and E-cadherin (blue) and counterstained with DAPI (not shown). a, airway with associated smooth muscle; *, bead
location. Phosphohistone H3 staining (not shown) did not demonstrate any obvious differences in cell division surrounding the beads.
(F) Close up of the region in (E) around the PDGF-B bead that has initiated arterial wall formation as shown by induction of PDGFR-b and SMA expression.
(G–I) Confocal optical sections of left PAs from whole mount E14 wild-type (G) and PDGF-B(/) (H) littermate lungs stained for SMA, PDGFR-b and nuclei (DAPI)
as indicated. Marker expression patterns are quantified in I, and values shown are fraction of cells in each layer with the indicatedmarker expression profile. Three
wild-type PAs (n = 96 cells) and two PDGF-B(/) PAs (48 cells) were scored. There is no detectable phenotype in the mutant.
(J–M) Confocal images of left PAs from whole mount E12 lungs of the indicated genotypes, immunostained for SMA. Because PDGFR-a(/), PDGFR-b(/)
double mutants die before the PA wall forms, double mutant shown in L is a lung-mesenchyme-specific (LM) double knock-out of genotype PDGFR-a(flox/),
PDGFR-b(/), Tbx4-Cre. Airway branching, which is stereotypically correlated with PA development, is maintained in these mutants (data not shown). Genotype
of littermate control in (M) is PDGFR-a(flox/+), PDGFR-b(+/+), Tbx4-Cre. Compound PDGFR-a(+/), PDGFR-b(/) embryos at E11.5–12.5 did not show lung
developmental delay or a PA phenotype (data not shown).
Scale bars, 100 mm (C and E) and 10 mm (F, H, K, and M). See also Figure S5.
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chymal cells, would dictate arterial wall identity, the sequence
in which these identities arise and the pattern of cell division.
Mesenchymal cells directly adjacent to the endothelium,
exposed to the highest level of signal, would be the first to induce488 Developmental Cell 23, 482–493, September 11, 2012 ª2012 Elsthe smooth muscle program and would proliferate most. As the
signal spreads, surrounding mesenchymal cells would initiate
the program and begin forming the next layer. The accumulating
gradient would also polarize inner layer cells and radially
reorient cell division and migration to promote invasion of theevier Inc.
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outermost mesenchymal cells would be sufficient to initiate
but not complete the smooth muscle program, creating the
adventitial layer.
PDGF-B Is One of Multiple Radial Patterning Signals
The ligand PDGF-B is an attractive candidate for the radial
patterning signal. It has been implicated in VSMC and pericyte
(vascular wall cells associated with capillaries) development
(Andrae et al., 2008; Hoch and Soriano, 2003; Lindahl et al.,
1997), and it is expressed in ECs of the developing PA starting
at the time the arterial wall begins to form (Figure 5C and data
not shown). Its receptors PDGFR-a and PDGFR-b are expressed
in an overlapping pattern, complementary to that of PDGF-B, in
the surrounding mesenchyme of the early lung (Figures 1G, 1I,
and S5A). When PDGF-B-loaded agarose beads were implanted
in E12 embryonic lung cultures, a nascent arterial wall up to two
layers thick of PDGFR-b+, SMA+ cells began to form around the
bead (Figures 5D–5F and S5E–S5G). Many of these cells were
not in direct contact with the bead, suggesting that PDGF-B
diffuses away from the bead, forming a local gradient that
induces nearby mesenchymal cells to initiate arterial wall
formation. Later steps in the arterial wall program, such as
downregulation of PDGFR-b expression, did not occur, perhaps
because of a requirement for additional signals or declining
viability of the explant.
Despite the appropriate expression patterns of PDGF-B and
its receptors during arterial wall formation and the ability of
PDGF-B to initiate PA wall formation in explants, we found that
radial patterning of the PA in mutant embryos null for PDGF-B
was indistinguishable from that in wild-type embryos (Figures
5G–5I). Similar results were obtained for PDGFR-a(/) or
PDGFR-b(/) mutants or conditional PDGFR-b gain of function
mutants (Figures 5J, 5K, S5B–S5D, and data not shown).
However, an early step in the process was inhibited in double
mutants lacking both PDGF receptors in lung mesenchyme
(PDGFR-a(flox/), PDGFR-b(/), Tbx4-Cre) (Figures 5L and 5M).
Taken together, results of these genetic experiments and the
PDGF-B bead experiments implicate PDGF involvement in radial
patterning but indicate redundancy among both the ligands and
receptors.
Although it would be elegant if the radial patterning signal was
a single diffusible factor, our results suggest it is an ensemble of
factors, including PDGF-B and at least one other as yet uniden-
tified signal. Multiple factors would provide flexibility in the
control of vessel wall structure, important in generating the diver-
sity of such structures and disease phenotypes (see below). And,
although it is simplest to think of the factors as diffusible like
PDGF-B from the beads, certain features of the process (e.g.,
the temporal aspect of radial SMC differentiation patterning)
could be accounted for bymembrane-bound signals transmitted
radially via a sequential, contact-dependent (‘‘bucket brigade’’)
signaling process (Feng et al., 2010; Hoglund and Majesky,
2012; Manderfield et al., 2012).
Implications of the Radial Patterning Model for Arterial
Diversity and Disease
Other blood vessels have different radial structures than the PA.
For example, at the end of gestation, the left common carotidDevelopmenartery (CCA) and aorta have two or three times the number of
smooth muscle layers as the PA, whereas the left anterior de-
scending coronary artery has just a single layer (Figures 1B,
1C, and 6A–6D; data not shown). An analysis of SMA expression
and fate mapping of the developing left CCA showed that, as for
the PA, the CCA wall forms radially from the inside-out (Figures
6F–6J) with inner layer cells migrating radially to contribute to
outer layers (Figures 6K and 6L). An initial clonal analysis of the
descending thoracic aorta indicates that, here too, inner layer
cells migrate radially to contribute to outer layers (A. Misra,
L.D., and D.M.G., unpublished data). Thus, despite their differing
radial structures, at least some of the same cellular mechanisms
are used to form them.
An appealing idea is that vessel-specific modulation of the
radial patterning signal(s) and response thresholds generate
the observed differences in vessel wall sizes and structures
(Figure 6E), and we further speculate that dysregulation of
such signaling contributes to the many vascular diseases in
which the radial structure of the vessel wall is altered and
SMCs become highly proliferative and motile (Owens et al.,
2004), resembling the developmental state (Figure 6O). Indeed,
conditional activation of PDGFR-b, which presumably extends
and levels the PDGF signaling gradient, markedly increases the
thickness of the aorta (Olson and Soriano, 2011; Figures 6M
and 6N), and targeted deletion of the PDGF-B matrix retention
motif also alters vessel walls (Lindblom et al., 2003; Nystro¨m
et al., 2006). It must now be a priority to identify the full set of
signals that control induction of cell layers and radial invasion,
and how generally these pathways and cellular mechanisms op-
erate in development and diseases of each arterial wall. Such
pathways and mechanisms would be appealing therapeutic
targets for arterial wall diseases and regenerative strategies.
EXPERIMENTAL PROCEDURES
Animals
All experiments with animals were approved by the IACUC at Stanford or Yale
University School of Medicine. CD1 mice (Charles Rivers Laboratories) were
used for wild-type analysis. PDGF-B(+/) (Leve´en et al., 1994), PDGFR-aGFP
(Hamilton et al., 2003), PDGFR-b(+/) (Soriano, 1994), PDGFR-b-Cre (Foo
et al., 2006), SMMHC-CreERT2 (Wirth et al., 2008), Rainbow (Rb) Cre reporter
ROSA26RRb (Red-Horse et al., 2010), and PDGFR-bJ (Olson and Soriano,
2011) mice have been described. PDGFR-aflox, Ptch1lacZ, Wt1-CreERT2,
VE-cadherin-Cre, Wnt1-Cre, Shh-Cre, SM22-Cre and the Cre reporter strains
ROSA26RlacZ,ROSA26RYFP, andROSA26RmTmGwere obtained from Jackson
Laboratories. The Tbx4-Cre and Tbx4-CreERT2 transgenes are lung mesen-
chyme-specific and induce expression of Cre reporters beginning at E10
and throughout the undifferentiated mesenchyme as well as in mesenchymal
derivatives, including airway and vascular SMC, but not in airway epithelium
(M.K., P. Bogard, andM.A.K., unpublished data; Menke et al., 2008); construc-
tion and use of the transgenes and transgenic mice will be detailed elsewhere
(M.K., P. Bogard, and M.A.K., unpublished data).
Immunohistochemistry and Histology
Embryos and lungs from timed pregnancies, in which noon of the day of
vaginal plug detection was designated E0.5, were dissected and fixed in
4% paraformaldehyde (PFA) for 0.5–2 hr. For hematoxylin and eosin (H&E)
staining, fixed tissue was dehydrated in methanol, and paraffin sections
were prepared and stained using standard protocols. For b-galactosidase
activity stains, fixed whole mount lungs were incubated with bromo-chloro-
indolyl-galactopyranoside (X-gal, Sigma). For immunostains of whole mount
lungs (Metzger et al., 2008), fixed lungs were dehydrated serially into 100%
methanol and stored at 20C. Lungs were rehydrated and incubated withtal Cell 23, 482–493, September 11, 2012 ª2012 Elsevier Inc. 489
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Figure 6. Radial Patterning in Arterial Diversity and Disease
(A–D) Transverse sections of the left anterior descending coronary artery and the left pulmonary and left common carotid arteries (CCA) and aorta at E17,
stained for SMA (red), EC marker (VE-cadherin in A and PECAM in B–D; white) and DAPI (nuclei, blue). Walls range from one to five smooth muscle layers thick.
(E) Differences in the radial signal gradient (see Figure 5B) could determine the thickness of specific developing arteries.
(F–J) Sections through the developing left CCA (C) at the embryonic ages indicated and stained with SMA (red), PECAM (white), and DAPI (nuclei, blue). (F–H are
longitudinal sections of the third aortic arch artery, which later becomes the CCA, and I, J are transverse sections of the CCA.) Note the gradual increase in SMA+
cell layers from rare first layer cells at E10.5 to four continuous circumferentially elongated layers at E16.5.
(K and L) Fatemapping of CCA first layer SMCmarker+ cells in SMMHC-CreERT2, ROSA26RmTmG/+ embryos induced with a single low dose of tamoxifen (0.5mg)
at E10.25. First layer CCA SMCs give rise to outer layer SMCs (marked by *), as for the PA (Figures 4D, 4E, S3E, S3E0, and S4). Despite the different sizes and
origins of the vascular wall cells (PA from mesenchyme, see Figures 1F, 1J, and S1C; CCA from neural crest, see Jiang et al., 2000; Le Lie`vre and Le Douarin,
1975), radial invasion occurs in both vessels.
(M and N) Transverse sections of descending aortic walls stained for SMA, PECAM and nuclei (DAPI) in control (M, SM22-Cre) and a conditional PDGFR-b gain-
of-function mutation activated specifically in smooth muscle (N, PDGFR-b(+/J), SM22-Cre indicated by PDGFR-b*). (The PDGFR-bJ allele, a V536A mutation that
disrupts an inhibitory juxtamembrane region and results in constitutive PDGFR-b activity, is a knock-in at the endogenous PDGFR-b locus; Olson and Soriano,
2011.) Note that the mutant wall has more than twice the normal number of smooth muscle layers but the normal number of elastic layers (i, e, o) (N; Olson and
Soriano, 2011), whereas in the PA there was no observable phenotype (see Figure S5D).
(O) Changes in the radial signaling gradient may contribute to diseases characterized by vessel wall thickening or thinning. E, endothelial layer; 1–9, smooth
muscle layers 1–9; Lu, vessel lumen; i, internal elastic lamina; e, elastic lamina; o, external elastic lamina. Scale bars, 10 mm.
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Radial Construction of an Arterial Wallblocking solution (5% rabbit or goat serum, 0.5% Triton X-100 in PBS) and
then with primary antibodies diluted in blocking solution overnight at 4C.
On the next day, lungs were washed with blocking solution, followed by
incubation with fluorescent-conjugated secondary antibodies overnight at
4C. For signal amplification, a biotin-conjugated antibody was substituted,
and then lungs were incubated with the ABC Elite reagent (Vector) and FITC,
Cy3, or Cy5 Tyramide Reagent (Perkin Elmer). For immunostains of cryosec-
tions (Red-Horse et al., 2010), fixed tissue was cryoprotected in 30% sucrose490 Developmental Cell 23, 482–493, September 11, 2012 ª2012 Elsovernight at 4C, frozen in optical cutting temperature compound (OCT,
Tissue Tek) and stored at 80C. Tissue was sectioned (10–20 mm), washed
in PBS, and immunostained as described above for wholemount lungs, except
sections were incubated with secondary antibodies at room temperature
for 1 hr.
Primary antibodies used were anti-CD31 (rat 1:100–200, BD PharMingen; or
hamster 1:100, Serotec), anti-VE-cadherin (1:100, BD PharMingen), anti-E-
cadherin (1:500–1000, Invitrogen), anti-NG2 (1:200, Millipore), anti-SMMHCevier Inc.
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Radial Construction of an Arterial Wall(1:100, Biomedical Technologies), anti-SM22-alpha (1:500, Abcam), anti-
PDGFR-a (1:50, R&D), anti-GFP (1:500, Abcam), anti-phosphohistone H3
(pH3; 1:100–200, Millipore), anti-acetylated tubulin (1:500, Sigma), anti-Sca1
(1:100, BD PharMingen), directly conjugated FITC or Cy3 anti-alpha-SMA
(1:100–1:200, Sigma), and biotinylated anti-PDGFR-b (1:50–100, R&D).
Secondary antibodies were conjugated to either Alexa 488, 555, 647
(Molecular Probes), or Dylight 649 (Jackson Labs) fluorophores or to
biotin (1:250). Note that mTomato fluorescence from the unrecombined
ROSA26RmTmG allele is weak in lung cryosections or methanol-treated
whole mount lungs, and certainly insignificant compared to the signal from
immunostains with the anti-alpha-SMA antibody directly conjugated to Cy3.
To mark nuclei, tissue was stained with DAPI (1:1,000).
The positions of PA wall cells were identified as located in layer 1 (L1; i.e.,
the cell layer adjacent to the ECs), 2 (L2; the next radial layer), or adventitia
(A; the following outer layer). The identity of layer A as adventitia should be
considered provisional because these cells did not detectably express Sca1
or Ptch1lacZ, the extant adventitial markers that label adventitia of select
regions of specific vessels starting late in embryogenesis (Majesky et al.,
2011; Passman et al., 2008). For quantification of marker expression profiles
in PA wall layers, longitudinal confocal sections and vascular wall cells in
each section were assessed as described below for phosphohistone cell
counts. L1 cells of each section were numbered sequentially around the
vessel and subdivided into groups of five contiguous cells. One cell was
randomly selected from each group, and the marker expression was deter-
mined for this L1 cell as well as for the adjacent cell in L2 and the successive
adjacent cell in A.
In Situ Hybridization
Dehydrated whole mount lungs were rehydrated into PBS with 0.1% Tween-
20, permeabilized with proteinase K (10 mg/ml) and fixed again in 4% PFA
with 0.2% glutaraldehyde (Sigma). Lungs were then hybridized at 68C
with digoxigenin (DIG)-labeled (Roche) probes overnight, washed extensively
in saline sodium citrate solution, and incubated with alkaline phosphate-
conjugated anti-DIG antibodies at 4C overnight. Nitro blue tetrazolium
chloride/5-bromo-4-chloro-30-indolyphosphate p-toluidine salt (NBT-BCIP)
was used to detect signal, and lungs were then washed extensively with
TBS/0.1% Tween-20/10 mM EDTA. Tissue sections (10–20 mm) were hybrid-
ized and stained as described (Red-Horse et al., 2010).
Phosphohistone Cell Counts and Mitotic Axis
Whole mount lungs stained with antibodies against pH3, SMA, and PDGFR-
b and with DAPI were imaged by confocal fluorescence microscopy in the
coronal plane to obtain longitudinal optical sections of the left PA extending
from the carina to the first left lateral secondary airway branch (LL1). The
longitudinal section of the left PA closest to the carina was the starting section
and subsequent sections were collected every 12–20 mm (1 cell length) until
the vessel crossed LL1. Sections were considered adequate for analysis if the
lumen and at least four cell lengths in the longitudinal axis of the vessel wall
were visible. Sections containing wall cells visualized on previous sections
were omitted. Vascular wall cells were identified as located in L1, L2, or A.
This analysis included cells on the medial or lateral aspect of the blood vessel
wall but excluded cells at the proximal or distal end of each vessel section
because the layer these cells reside in could not be reliably determined.
Between the carina and the LL1 airway branch, the left PA curves dorsal-
ventrally, precluding definitive assignment to a specific wall layer at the
proximal or distal end of each coronal section of the vessel. For mitotic axis
counts, cells were only included in the analysis if they were pH3+ and the
division axis of the mitotic figure was clearly determinable. The long axis of
the PA endothelium was defined as the longitudinal axis, and mitotic angles
were scored relative to this axis and binned into three groups: longitudinal,
radial, or 45. However, no mitotic figures in the 45 group were observed.
An analysis of pH3-stained mitotic figures co-stained for acetylated tubulin
to show themitotic spindle confirmed the fidelity of this approach for assigning
axis of division (data not shown).
Clonal Analysis
SMMHC-CreERT2mice were crossed to either ROSA26RmTmG or ROSA26RRb
(‘‘Rainbow’’) mice. A single limiting dose (0.8–1.2 mg, see below) of tamoxifenDevelopmen(Sigma) was injected intraperitoneally into dams at E11.5 to induce recombina-
tion. Embryos were allowed to continue development and then analyzed at
E13.5–18.5. For mGFP labeled clones, whole mount lungs were dissected
and stained with an anti-GFP antibody in whole mount preparations for
E13.5–14.5 lungs, or in cryosections for E17.5–18.5 lungs. Each GFP+ cell
was counted and its specific location and layer in the left PA wall recorded,
except for cells at the proximal or distal end of each vessel section, which
as described above could only be assigned to a ventral or dorsal location
but not a specific layer of the PAwall. For Rainbow clones, tissue was cryosec-
tioned and imaged using fluorescent filters for each fluorophore, and each
marked cell was scored for color (i.e., Cerulean, mOrange, or mCherry), posi-
tion, and specific layer of the PA wall.
To find conditions of very sparse and, ideally, single cell (i.e., clonal)
marking of left PA SMCs we titrated down the dose of tamoxifen injected at
E11.5 in preliminary experiments. In the range used here (0.8–1.2 mg), we
found that 48% of SMMHC-CreERT2, ROSA26RmTmG/+ embryos had
marked cells in the PA and the rest had none. Lower doses (0.6 mg) gave
no GFP+ PA SMCs at E13.5 (n = 6), whereas higher doses (1.5 mg) yielded
more embryos (83%) with marked cells and more GFP+ cells in the marked
embryos. To help ensure clonal labeling, we excluded from analysis any
embryos in which there was not at least one SMMHC-CreERT2,
ROSA26RmTmG/+ littermate lacking marked cells. At standard doses of tamox-
ifen (0.8–1.2 mg) in SMMHC-CreERT2, ROSA26RRb/+ embryos (n = 63), the PA
SMCs were almost always unlabeled (59%) or labeled with just a single color
(38%), confirming clonality, and only very rarely (n = 2) were multi-color (i.e.,
polyclonal; 3%).
In these experiments, the labeled parent cell is always an inner layer SMC
because expression of SMC markers (and presumably SMMHC-CreERT2) is
limited to this layer until three days after tamoxifen injection (i.e., E14.5; see
Figures 2 and S2), and analysis of clones marked at E11.5 and analyzed at
E13.5 showed labeling of only inner layer cells. In embryonic studies from other
groups utilizing highly active promoters driving CreER, the time window for
recombination of Cre reporters is 6–48 hr following a single injection of high-
dose tamoxifen (1.5–3.0 mg) (Hayashi and McMahon, 2002; Nakamura et al.,
2006). We found that injection of our standard dose of tamoxifen (1.2 mg) at
E10.5, instead of E11.5, resulted in no marked left PA SMCs in SMMHC-
CreERT2, ROSA26RmTmG/+ embryos at E13.5 (n = 8). Because SMMHC protein
(and presumably SMMHC-CreERT2) is expressed in the PA SMCs at E11.5
(Figure S2F), these findings suggest that the outer time limit for recombination
in the left PA following a 1.2 mg injection is 1 day or less. Although there were
no marked PA SMCs in these experiments, there were marked airway SMCs
because expression of SMC markers, presumably including SMMHC-
CreERT2, occurs earlier in the airways than in the vessels. Similarly for
SMMHC-CreERT2, ROSA26RRb/+ embryos from dams injected with tamoxifen
at E11.5, PA SMCs were almost always unlabeled or labeled with a single
color, but airway SMCs invariably contained marked cells of all three colors
(Figure S3F).
Lung Cultures and PDGF Bead Implantation
Agarose beads (Affi-Gel Blue Gel, 100–200 mesh, Bio-Rad) were washed
with sterile PBS three times for 30 min each, and then incubated for one
hour with a disulfide linked homodimer of PDGF-B (R&D, 200–300 ng/ml)
in PBS or with PBS alone for control beads (Furuta et al., 1997). After
incubation, the beads were briefly washed and then implanted in the
mesenchyme of freshly harvested E12 whole mount lungs by making a
small incision in the lung mesenchyme with flame-polished tungsten needles
and carefully positioning the bead. Lungs were cultured in DMEM12 with
10% FBS on 0.4 mm filters (Millipore) at the air liquid interface for 24–72 hr
in a 5% CO2 incubator, then fixed with 4% PFA and immunostained as
above. Lungs that did not grow normally in culture were excluded from
analysis.
Imaging
Tissue samples were imaged on a Leica MZ12 stereomicroscope (whole
mounts) or on Zeiss Axiophot or Nikon Eclipse 80i fluorescence microscopes
or on Leica CTR6000 or Nikon Eclipse Ti-Perkin Elmer Ultraview VoX
confocal microscopes. Adobe Photoshop was used to process images and
overlays.tal Cell 23, 482–493, September 11, 2012 ª2012 Elsevier Inc. 491
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